Trial Profile
A retrospective study to evaluate the efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Raltegravir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 03 Dec 2015 New trial record